Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Conte

Showing results (31-40 of 320) with videos related to

Pageof 32
Sort By:
Advanced Drug Delivery Reviews|July 23, 2020
Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapyAlexander S Kim, Michael S Conte
Journal of Vascular Surgery|August 24, 2021
A critical appraisal of registry-based objective performance goals in peripheral arterial diseasePatrick J Geraghty, Michael S Conte
Cardiovascular Drug Reviews|October 9, 2007
Edifoligide: a transcription factor decoy to modulate smooth muscle cell proliferation in vein bypassAndrew W Hoel, Michael S Conte
Evidence-Based Medicine|June 10, 2010
Aspirin prophylaxis (100 mg daily) does not improve cardiovascular outcomes compared to placebo in asymptomatic individuals with incidental low-ankle brachial indexS Marlene Grenon, Michael S Conte
Circulation Research|April 25, 2015
Surgical intervention for peripheral arterial diseaseShant M Vartanian, Michael S Conte
Journal of Vascular Surgery|February 28, 2015
Society for Vascular Surgery Practice guidelines for atherosclerotic occlusive disease of the lower extremities management of asymptomatic disease and claudication. IntroductionMichael S Conte, Frank B Pomposelli
Current Opinion in Cardiology|August 7, 2024
The importance of optimal medical therapy in patients undergoing lower extremity bypassClara M Gomez-Sanchez, Michael S Conte
Journal of Vascular Surgery Cases and Innovative Techniques|May 8, 2023
Case planning and execution of inframalleolar bypass for chronic limb-threatening ischemiaClara M Gomez-Sanchez, Michael S Conte
Journal of Vascular Surgery|December 23, 2019
ReplyMichael S Conte, Andrew W Bradbury, Philippe Kolh
Journal of Vascular Surgery|November 21, 2022
ReplyMichael S Conte, Andrew W Bradbury, Philippe Kolh
Pageof 32

Showing results (31-40 of 320) with videos related to

Sort By:
Pageof 32
Advanced Drug Delivery Reviews|July 23, 2020
Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapyAlexander S Kim, Michael S Conte
Journal of Vascular Surgery|August 24, 2021
A critical appraisal of registry-based objective performance goals in peripheral arterial diseasePatrick J Geraghty, Michael S Conte
Cardiovascular Drug Reviews|October 9, 2007
Edifoligide: a transcription factor decoy to modulate smooth muscle cell proliferation in vein bypassAndrew W Hoel, Michael S Conte
Evidence-Based Medicine|June 10, 2010
Aspirin prophylaxis (100 mg daily) does not improve cardiovascular outcomes compared to placebo in asymptomatic individuals with incidental low-ankle brachial indexS Marlene Grenon, Michael S Conte
Circulation Research|April 25, 2015
Surgical intervention for peripheral arterial diseaseShant M Vartanian, Michael S Conte
Journal of Vascular Surgery|February 28, 2015
Society for Vascular Surgery Practice guidelines for atherosclerotic occlusive disease of the lower extremities management of asymptomatic disease and claudication. IntroductionMichael S Conte, Frank B Pomposelli
Current Opinion in Cardiology|August 7, 2024
The importance of optimal medical therapy in patients undergoing lower extremity bypassClara M Gomez-Sanchez, Michael S Conte
Journal of Vascular Surgery Cases and Innovative Techniques|May 8, 2023
Case planning and execution of inframalleolar bypass for chronic limb-threatening ischemiaClara M Gomez-Sanchez, Michael S Conte
Journal of Vascular Surgery|December 23, 2019
ReplyMichael S Conte, Andrew W Bradbury, Philippe Kolh
Journal of Vascular Surgery|November 21, 2022
ReplyMichael S Conte, Andrew W Bradbury, Philippe Kolh
Pageof 32